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Abstract
Background
The implementation of successful strategies to achieve an HIV cure has become a priority in
HIV research. However, the current location and size of HIV reservoirs is still unknown since
there are limited tools to evaluate HIV latency in viral sanctuaries such as gut-associated
lymphoid tissue (GALT). As reported in the so called “Boston Patients”, despite undetect-
able levels of proviral HIV-1 DNA in blood and GALT, viral rebound happens in just few
months after ART interruption. This fact might imply that current methods are not sensitive
enough to detect residual reservoirs. Showing that, it is imperative to improve the detection
and quantification of HIV-1 reservoir in tissue samples. Herein, we propose a novel non-
enzymatic protocol for purification of Lamina Propria Leukocytes (LPL) from gut biopsies
combined to viral HIV DNA (vDNA) quantification by droplet digital PCR (ddPCR) to improve
the sensitivity and accuracy of viral reservoir measurements (LPL-vDNA assay).
Methods
Endoscopic ileum biopsies were sampled from 12 HIV-1-infected cART-suppressed sub-
jects. We performed a DTT/EDTA-based treatment for epithelial layer removal followed by
non-enzymatic disruption of the tissue to obtain lamina propria cell suspension (LP). CD45+
cells were subsequently purified by flow sorting and vDNA was determined by ddPCR.
Results
vDNA quantification levels were significantly higher in purified LPLs (CD45+) than in bulk
LPs (p<0.01). The levels of vDNA were higher in ileum samples than in concurrent PBMC
from the same individuals (p = 0.002). As a result of the increased sensitivity of this
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purification method, the Poisson 95% confidence intervals of the vDNA quantification data
from LPLs were narrower than that from bulk LPs. Of note, vDNA was unambiguously quan-
tified above the detection limit in 100% of LPL samples, while only in 58% of bulk LPs.
Conclusion
We propose an innovative combined protocol for a more sensitive detection of the HIV res-
ervoir in gut-associated viral sanctuaries, which might be used to evaluate any proposed
eradication strategy.
Introduction
There is an emerging interest in developing safe and affordable curative strategies that would
eliminate the need for lifelong antiretroviral therapy (ART) in HIV-1 infected patients,
improving the health status and reducing the risk of viral transmission to uninfected individu-
als. In most clinical trials, HIV-1 plasma RNA and cell-associated viral DNA (vDNA), as well
as replication-competent reservoir in circulating CD4+ T cells, are the primary end-points ana-
lyzed to assess the impact of the different curative strategies, as resting memory CD4+ T cells
represent the largest number of latently infected cells [1]. However, the vast majority of these
cells reside in other anatomical sites such as spleen, lymph nodes, gastrointestinal mucosa and
respiratory tract, and the cell equilibrium between them is not well established [2]. From them,
the population of T cells in gut-associated lymphoid tissue (GALT) stands for more than 60%
of the total body lymphocytes [3]. Of note, gastrointestinal lamina propria is a major site of
viral replication and CD4+ T cell depletion during acute infection [4,5].
Several studies have demonstrated the persistence of HIV-1 infection in gut-associated CD4+
memory T cells in long-term suppressed HIV-1-infected patients [6,7]. However, as reported in
the so called “Boston Patients”, despite undetectable levels of proviral HIV-1 DNA in blood and
GALT tissue, viral rebound can happen in just few months after ART recess [8]. This fact might
imply that current methods are not sensitive enough to detect residual reservoirs, so new
approaches are needed to better define and quantify HIV-1 reservoirs in tissue samples.
In gut biopsies, vDNA quantification has frequently been done in the bulk from snap-fro-
zen tissue or in cell suspensions, which are obtained in fresh after collagenase digestion and
mechanical disruption [9–17]. Albeit vDNA is frequently detected in samples from ART-
treated patients by this method, the limit of detection is lowered as a result of the low fre-
quency, about 1%, of CD4+ T cells in those samples [10]. Thus, current guidelines recommend
a lymphocyte purification step to improve proviral quantification [18]. Still, substantial cell
loss and phenotypic alterations might result from the use of enzymatic treatment, thus limiting
further functional analysis.
Previous work in HIV negative individuals proved that non-enzimatic methods in GALT
tissue cell isolation relay in higher yields of desired cells [19]. Moreover, sorting purification of
cell-populations enriched in latently HIV infected cells contributes to increase cell yield and
subsequent vDNA quantification [7,20]. Herein, to improve the sensitivity of vDNA quantifi-
cation from gut associated lymphoid tissue (GALT), we have developed a novel non-enzymatic
protocol for purification of lamina propria leukocytes (LPL) from gut biopsies prior vDNA
absolute quantification by droplet digital PCR (ddPCR). This new assay (referred now on as
LPL-vDNA, Fig 1) renders remarkable cell yield from gut biopsies and significantly increases
the sensitivity and robustness of vDNA quantification.
Quantification of HIV-1 reservoir in lymphoid tissue
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Methods
Participants and biopsy collection
We performed a substudy of 12 HIV-infected ART-suppressed individuals belonging to the
INDOOR Study (EudraCT number: 2014-004331-39) who were recruited at Vall d’Hebron
University Hospital (Barcelona, Spain). We simultaneously collected blood and ileum biopsies
from all these individuals. The participants gave their written informed consent, and the insti-
tutional review boards from Hospital Vall d’Hebron approved the protocol.
Ileum colonoscopies were performed following a standard procedure. Briefly, subjects
underwent a free-fiber diet for 3 days prior the procedure, and had to be in fast condition the
day of the colonoscopy. An entire colon exploration until the ileo-caecal valve was performed
searching for pathology and obtaining biopsies if needed. Once the ileo-caecal valve was visual-
ized, intubation of 10–15 cm of terminal ileum was performed with the endoscope to obtain
four to eight submucosal biopsies that were immediately placed in complete medium: RPMI
1640 with 10% fetal bovine serum (FBS, both from Gibco), supplemented with antibiotics
(500 μg/mL pipericillin/tazobactam, Fresenius Kabi) and 1.25 μg/mL amphotericin B
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Fig 1. Schematic representation of the LPL-vDNA assay. The cells in blue represent lymphocyte populations and in purple, myeloid populations. LPs:
lamina propria cells; LPLs: lamina propria leukocytes; O/N: overnight; ddPCR: droplet digital PCR.
https://doi.org/10.1371/journal.pone.0175899.g001
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(Fungizone, Gibco). Samples were shipped and processed within 1 hour after collection, in
order to minimize LPL loss and/or contamination.
Lamina Propria (LP) cell isolation from ileum biopsies
Biopsies were incubated in HBSS (without Ca2+/Mg2+, Gibco) containing 1 mM DTT (Sigma)
and 1 mM EDTA (Gibco) for 25 min, at room temperature with constant shaking, to remove
the epithelial layer. Then, biopsies were transferred again to complete media, containing anti-
fungal and antibiotics, and cultured overnight in 6-well low-binding plates (Costar), at 1–2
biopsies per well. Afterwards, culture supernatants were collected to recover the released cells,
and the remaining tissue was disrupted by gentle pipetting. Finally, cell suspensions were
cleared from tissue debris using a 40 μm nylon mesh (Falcon).
LP Leukocyte purification by cell sorting
In order to purify the leukocyte population, lamina propria cells (LPs) were resuspended in
PBS (Gibco) containing 2 mM EDTA and 2% FBS, and stained for 30 min at 4˚C with the fol-
lowing antibodies: CD45 (FITC), CD3 (APC) and CD8 (PercP) from Becton Dickinson. Sort-
ing of CD45+ cells was performed in a BD FACS Aria II Flow cytometer, selecting singlets
(FSC-H vs. FSC-A) and collecting CD45+ from the lymphocytes gate (SSC-A vs. FSC-A) (Fig
2). For further calculations, those CD45+ cells that were CD3+CD8− were assumed to be CD4+
T cells, which included those cells that have downregulated CD4 expression because of HIV-1
infection.
Finally, sorted CD45+ cells, assumed as lamina propria leukocytes (LPLs), were spun down
and resuspended in lysis buffer at a concentration of 5x103 – 5x104 cells/μl (minimum volume
of 10 μl). Lysis buffer consisted of 0.1% Triton x-100 (Sigma) and 400 μg/ml Proteinase K
(Ambion) in 10 mM Tris-HCl pH = 9.0 (Sigma). Cell lysates were incubated at 55˚C for 15–20
h, followed by a 5 minutes inactivation of proteinase at 95˚C, prior to storage at –20˚C.
Total vDNA quantification
Lysed extracts from purified LPLs (CD45+ cells), bulk LPs and PBMCs from the same partici-
pants were simultaneously obtained and used to measure cell-associated HIV-1 DNA by
ddPCR. A total of 2–3 μl of cell lysates were mixed with ddPCR supermix and primers/probes
(FAM/HEX-ZEN-Iowa BlackFQ double-quenched probes, Integrated DNA Technologies) in
a total volume of 20 μl to generate droplets, according to manufacturer’s recommendations.
We managed to circumvent potential primer mismatch in individuals’ viral sequence by using
two different primers/probe sets annealing to the 5’LTR and GAG conserved regions of HIV-1
Fig 2. Representation of the gate strategy followed for LPLs isolation. Sorted CD45+ cells (LPLs) were framed in the red box.
https://doi.org/10.1371/journal.pone.0175899.g002
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genome [21–23] (Table 1). Here, ddPCR Supermix for Residual DNA quantification was used
(186–4037, Bio-Rad). Annealing/extension step was set at 57˚C to quantify vDNA using the
C1000 Touch™ Thermal Cycler (Bio-Rad) and subsequently analyzed using a QX100™ droplet
reader (Bio-Rad) and the QuantaSoft v.1.6 software (Bio-Rad).
PBMCs, bulk LPs and LPLs samples were quantified in duplicate or triplicate, respectively.
PBMCs from HIV-negative donors were used as negative controls and assayed in each plate to
set the positive/negative threshold for ddPCR analysis, and the number of those negative con-
trol wells was the same than replicas for each sample. The RPP30 cellular gene was quantified
in parallel to normalize sample input (Table 1) [24].
Results
Participants characteristics
The detectability improvement of the novel LPL—vDNA assay (Fig 1) was evaluated in ileum
samples from 12 HIV-1-infected individuals. All of them were on suppressive ART composed
of two reverse transcriptase inhibitors plus one boosted protease inhibitor. Clinical details of
participants included in this substudy are summarized in Table 2. Specifically, at the time of
biopsy collection, the median time on suppressive ART was 5 years (interquartile range: 1.3–
9.8), and the median CD4+ T-cell count was 585 cells/μl (interquartile range: 505–700).
Cell isolation efficiency of LPL-vDNA assay
After the LPLs isolation protocol, based on a non-enzymatic method, the median number of
leukocytes (CD45+ cells) recovered was 4.8x104 cells per biopsy (interquartile range, 3.2–
6.0x104), which included CD4+ T cells (median of 29.4% of CD3+CD8- cells in CD45+ cells).
Table 1. Primers and probes used for vDNA quantification.
Target Primer/probe Name Sequence (5’-3’) Strand
HIV-1 U5’-LTR LTR-U5 integrated GTTCGGGCGCCACTGCTAG Forward
LTR-R integrated TTAAGCCTCAATAAAGCTTGCC Reverse
New integrated-2 Probe CCAGAGTCACACAACAGACGGGCA Probe
HIV-1 GAG HIV_F (SCA) CATGTTTTCAGCATTATCAGAAGGA Forward
HIV_R (SCA) TGCTTGATGTCCCCCCACT Reverse
HIV Probe (SCA) CCACCCCACAAGATTTAAACACCATGCTAA Probe
Cellular RPP30 gene RPP30-F GATTTGGACCTGCGAGCG Forward
RPP30-R GCGGCTGTCTCCACAAGT Reverse
RPP30 Probe CTGACCTGAAGGCTCT Probe
https://doi.org/10.1371/journal.pone.0175899.t001
Table 2. Participants’ characteristics at baseline.
n = 12
Age (years), median [IQR] 53 [49–58]
Male, n (%) 8 (67)
Time from HIV-1 diagnosis (years), median [IQR] 21 [17–27]
Time suppressed (years), median [IQR] 5 [1.3–9.8]
CD4+ T-cell count (absolute cells/μl), median [IQR] 585 [505–700]
https://doi.org/10.1371/journal.pone.0175899.t002
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Total proviral DNA quantification comparison in PBMCs, LPLs and bulk
LPs
For the absolute quantification of cells harboring proviral DNA, up to 3x105 cells were lysed
and directly tested by droplet digital PCR (ddPCR). As shown in Fig 3, vDNA detection by
ddPCR was highly improved by LPLs purification by cell sorting of CD45+ cells, compared
with bulk LPs from the same biopsy.
Despite inter-individual variability, the LPL-vDNA quantification levels were significantly
higher in the purified leukocyte population (CD45+) than in the unsorted cell suspension
(p<0.01, Fig 4A). As expected, the levels of vDNA were higher in ileum samples than in
peripheral blood mononuclear cells from the same participants (PBMCs, p = 0.002, Fig 4A)
As a result of the increased sensitivity of this purification method, the Poisson 95% confi-
dence intervals of the vDNA quantification data from LPLs (CD45+) were narrower than that
from bulk LPs (Fig 4B). Of note, vDNA was unambiguously quantified above the detection
limit in 100% of LPL-purified samples, while only in 58% of bulk LP samples.
Discussion
In this study, we aimed to enhance sensitivity and robustness of vDNA quantification from
gut biopsies. As lamina propria leukocytes (LPLs) are mainly CD4+ T cells in healthy individu-
als, and it is a preferential site for HIV-1 replication, we first set up a novel protocol for LPLs
recovery from ileum samples. As described by Mahida et al. [25], epithelial layer removal with
DTT prior to 16-hour biopsy culture, allows for spontaneous cellular release from the tissue,
thus facilitating disruption of the tissue in absence of enzymatic methods. This method has
previously shown to result in greater LPLs yield and purity than enzymatic tissue dissociation,
either by low-dose or high-dose collagenase treatment [19]. Further modification of the
Fig 3. Droplet digital PCR dot plot for GAG amplification. Representative results from LPs (pre-sorting),
LPLs (post-sorting) and negative controls.
https://doi.org/10.1371/journal.pone.0175899.g003
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original protocol by the addition of piperacillin-tazobactam to the collection and culture
media prevented microbial contamination from intestinal flora in our tissue cultures by 95%
[26]. Minimal cell loss or contamination occurred if samples were shipped just after biopsy
collection or after epithelial removal (data not shown). Consequently, this protocol overcomes
the need of specific equipment and trained staff at the site of specimen collection. Thus, LPLs-
vDNA assay enables multicenter recruitment and sample collection, while systematic process-
ing of tissue biopsies may be done in a reference laboratory [27].
Fig 4. Total HIV-1 DNA quantification by ddPCR. (A) Comparison of total vDNA quantification from LPLs, bulk LPs and PBMCs. (B)
Comparison of raw absolute vDNA quantification with Poisson 95% intervals from LPLs and bulk LPs. Clear dots represent the
quantifications with the minimum Poisson 95% interval under the limit of detection. Statistically significant p values are showed (Wilcoxon
signed rank test).
https://doi.org/10.1371/journal.pone.0175899.g004
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To increase the sensitivity of vDNA detection, LPLs were further purified by flow-based
sorting of CD45+ cells. This way, not only resting CD4+ T cells were tested for proviral content,
but also potential productively infected T cells with down-regulated CD4 expression. In addi-
tion, ddPCR has been previously demonstrated to be superior to qPCR, in terms of accuracy
and precision, for vDNA quantification in PBMCs [28]. In the LPL-vDNA protocol, the
advanced ddPCR technology is used for the first time to get absolute vDNA quantification in
gut leukocytes, thus enabling the opportunity to accurately evaluate the dynamics of gut HIV-
1 levels in interventional studies, as well as to detect low-level reservoir in cure strategies or
cohorts of natural or post-treatment controllers.
On consequence, we have developed an innovative combined protocol for a more sensitive
detection of the residual HIV infection in gut-associated viral sanctuaries. The combination of
epithelial removal and spontaneous cellular release from the tissue resulted in good recovery
of lamina propria leukocytes. Viral DNA determinations in the purified LPLs population ver-
sus the bulk lamina propria cell sample evidenced that the more purified is the sample; the
greater is the sensitivity in the detection of vDNA. Although the protocol has been imple-
mented in ileum biopsies, similar performance is expected with colon or rectum biopsies.
Thus the combination of the LPL isolation protocol with the more sensitive ddPCR method
would allow to accurately detect residual HIV infection in gut-associated viral sanctuaries.
Despite we are not measuring replication competent viruses, more sensitive molecular tech-
niques were needed since previous case reports showed HIV viral rebound despite negative
detection of HIV-DNA in gut biopsies [8]. This point makes this protocol relevant in the field,
as previous data on gut viral reservoirs in clinical studies had been obtained from total tissue
[8,9,11–16,29–31]. Thus, the LPL-vDNA technique might become a useful tool to understand
the virological outcome of any proposed eradication strategy and to make decisions about
treatment interruption.
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